BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15239143)

  • 1. Allelic loss but absence of mutations in the polyspecific transporter gene BWR1A on 11p15.5 in hepatoblastoma.
    Albrecht S; Hartmann W; Houshdaran F; Koch A; Gärtner B; Prawitt D; Zabel BU; Russo P; Von Schweinitz D; Pietsch T
    Int J Cancer; 2004 Sep; 111(4):627-32. PubMed ID: 15239143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.
    Hartmann W; Waha A; Koch A; Goodyer CG; Albrecht S; von Schweinitz D; Pietsch T
    Am J Pathol; 2000 Oct; 157(4):1393-403. PubMed ID: 11021841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma.
    Albrecht S; von Schweinitz D; Waha A; Kraus JA; von Deimling A; Pietsch T
    Cancer Res; 1994 Oct; 54(19):5041-4. PubMed ID: 7923113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma.
    Montagna M; Menin C; Chieco-Bianchi L; D'Andrea E
    J Cancer Res Clin Oncol; 1994; 120(12):732-6. PubMed ID: 7798299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas.
    Koch A; Weber N; Waha A; Hartmann W; Denkhaus D; Behrens J; Birchmeier W; von Schweinitz D; Pietsch T
    J Pathol; 2004 Dec; 204(5):546-54. PubMed ID: 15538750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma.
    Fukuzawa R; Umezawa A; Ochi K; Urano F; Ikeda H; Hata J
    Int J Cancer; 1999 Aug; 82(4):490-7. PubMed ID: 10404060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of molecular genetic alterations in hepatoblastoma.
    von Schweinitz D; Kraus JA; Albrecht S; Koch A; Fuchs J; Pietsch T
    Med Pediatr Oncol; 2002 Feb; 38(2):104-8. PubMed ID: 11813174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105.
    Yamada HY; Gorbsky GJ
    Oncogene; 2006 Mar; 25(9):1330-9. PubMed ID: 16314844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive allelotyping of hepatoblastoma.
    Terada Y; Matsumoto S; Bando K; Tajiri T
    Hepatogastroenterology; 2009; 56(89):199-204. PubMed ID: 19453057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
    Davies SM
    Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity on chromosome 11p15.5 and relapse in hepatoblastomas.
    Chitragar S; Iyer VK; Agarwala S; Gupta SD; Sharma A; Wari MN
    Eur J Pediatr Surg; 2011 Jan; 21(1):50-3. PubMed ID: 21053162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors.
    Wirths O; Waha A; Weggen S; Schirmacher P; Kühne T; Goodyer CG; Albrecht S; Von Schweinitz D; Pietsch T
    Lab Invest; 2003 Mar; 83(3):429-34. PubMed ID: 12649343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domain.
    Cooper PR; Smilinich NJ; Day CD; Nowak NJ; Reid LH; Pearsall RS; Reece M; Prawitt D; Landers J; Housman DE; Winterpacht A; Zabel BU; Pelletier J; Weissman BE; Shows TB; Higgins MJ
    Genomics; 1998 Apr; 49(1):38-51. PubMed ID: 9570947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver.
    Byrne JA; Simms LA; Little MH; Algar EM; Smith PJ
    Genes Chromosomes Cancer; 1993 Oct; 8(2):104-11. PubMed ID: 7504513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma.
    Iolascon A; Giordani L; Moretti A; Basso G; Borriello A; Della Ragione F
    Hepatology; 1998 Apr; 27(4):989-95. PubMed ID: 9537438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal- and tumor-specific regulation of growth hormone receptor messenger RNA expression in human liver.
    Zogopoulos G; Albrecht S; Pietsch T; Alpert L; von Schweinitz D; Lefèbvre Y; Goodyer CG
    Cancer Res; 1996 Jul; 56(13):2949-53. PubMed ID: 8674047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
    Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ
    Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.
    Weber RG; Pietsch T; von Schweinitz D; Lichter P
    Am J Pathol; 2000 Aug; 157(2):571-8. PubMed ID: 10934159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity on chromosome 1 in human hepatoblastoma.
    Kraus JA; Albrecht S; Wiestler OD; von Schweinitz D; Pietsch T
    Int J Cancer; 1996 Aug; 67(4):467-71. PubMed ID: 8759602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.